Bahl & Gaynor Inc Thermo Fisher Scientific Inc. Transaction History

Bahl & Gaynor Inc

$19.3 Billion
Q3 2024

A detailed history of Bahl & Gaynor Inc transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Bahl & Gaynor Inc holds 1,886 shares of TMO stock, worth $988,358. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,886

Previous 3,206 41.17%

Holding current value

$988,358

Previous $1.77 Million 34.2%

% of portfolio

0.01%

Previous 0.01%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$531.86 - $624.21 $702,055 - $823,957	-1,320 Reduced 41.17%	1,886 $1.17 Million
Q2 2024 Aug 07, 2024	SELL	$541.52 - $599.02 $67,690 - $74,877	-125 Reduced 3.75%	3,206 $1.77 Million
Q1 2024 May 10, 2024	BUY	$528.82 - $599.43 $21,152 - $23,977	40 Added 1.22%	3,331 $1.94 Million
Q4 2023 Feb 02, 2024	SELL	$431.41 - $532.94 $32,355 - $39,970	-75 Reduced 2.23%	3,291 $1.75 Million
Q3 2023 Nov 03, 2023	BUY	$498.29 - $574.41 $77,733 - $89,607	156 Added 4.86%	3,366 $1.7 Million
Q2 2023 Aug 14, 2023	SELL	$508.46 - $591.13 $825,739 - $959,995	-1,624 Reduced 33.6%	3,210 $1.67 Million
Q1 2023 May 03, 2023	BUY	$535.0 - $604.82 $3,210 - $3,628	6 Added 0.12%	4,834 $2.79 Million
Q4 2022 Feb 10, 2023	SELL	$484.71 - $571.37 $489,557 - $577,083	-1,010 Reduced 17.3%	4,828 $2.66 Million
Q3 2022 Nov 14, 2022	SELL	$507.19 - $604.49 $73,035 - $87,046	-144 Reduced 2.41%	5,838 $2.96 Million
Q2 2022 Aug 08, 2022	SELL	$500.9 - $612.21 $235,423 - $287,738	-470 Reduced 7.28%	5,982 $3.25 Million
Q1 2022 May 12, 2022	SELL	$524.0 - $644.92 $524 - $644	-1 Reduced 0.02%	6,452 $3.81 Million
Q4 2021 Feb 10, 2022	BUY	$569.0 - $667.24 $110,955 - $130,111	195 Added 3.12%	6,453 $4.31 Million
Q3 2021 Nov 15, 2021	BUY	$509.53 - $609.78 $509,530 - $609,780	1,000 Added 19.02%	6,258 $3.58 Million
Q2 2021 Aug 06, 2021	SELL	$441.0 - $508.24 $1.1 Million - $1.27 Million	-2,502 Reduced 32.24%	5,258 $2.65 Million
Q1 2021 May 11, 2021	SELL	$439.85 - $518.83 $610,071 - $719,617	-1,387 Reduced 15.16%	7,760 $3.54 Million
Q4 2020 Feb 02, 2021	BUY	$435.06 - $527.66 $186,205 - $225,838	428 Added 4.91%	9,147 $4.26 Million
Q3 2020 Nov 12, 2020	SELL	$359.77 - $441.52 $305,444 - $374,850	-849 Reduced 8.87%	8,719 $3.85 Million
Q2 2020 Aug 13, 2020	SELL	$275.2 - $362.34 $38,803 - $51,089	-141 Reduced 1.45%	9,568 $3.47 Million
Q1 2020 May 26, 2020	BUY	$255.3 - $340.05 $2.48 Million - $3.3 Million	9,709 New	9,709 $2.75 Million
Q1 2020 May 15, 2020	SELL	$255.3 - $340.05 $2.11 Million - $2.81 Million	-8,265 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$271.93 - $328.04 $90,824 - $109,565	-334 Reduced 3.88%	8,265 $2.69 Million
Q3 2019 Nov 14, 2019	BUY	$268.46 - $305.43 $16,912 - $19,242	63 Added 0.74%	8,599 $2.51 Million
Q2 2019 Aug 12, 2019	BUY	$257.51 - $295.55 $1.3 Million - $1.49 Million	5,034 Added 143.75%	8,536 $2.51 Million
Q1 2019 May 13, 2019	BUY	$212.17 - $273.72 $82,109 - $105,929	387 Added 12.42%	3,502 $959,000
Q4 2018 Feb 12, 2019	SELL	$208.47 - $251.98 $33,355 - $40,316	-160 Reduced 4.89%	3,115 $697,000
Q3 2018 Nov 09, 2018	SELL	$205.57 - $244.32 $82,228 - $97,728	-400 Reduced 10.88%	3,275 $799,000
Q2 2018 Aug 14, 2018	SELL	$203.14 - $219.53 $102,585 - $110,862	-505 Reduced 12.08%	3,675 $761,000
Q1 2018 May 11, 2018	SELL	$192.98 - $224.11 $27,789 - $32,271	-144 Reduced 3.33%	4,180 $863,000
Q4 2017 Feb 13, 2018	SELL	$182.03 - $200.37 $6,553 - $7,213	-36 Reduced 0.83%	4,324 $821,000
Q3 2017 Nov 13, 2017	SELL	$171.74 - $194.04 $8,587 - $9,702	-50 Reduced 1.13%	4,360 $825,000
Q2 2017 Aug 11, 2017	SELL	N/A	-30 Reduced 0.68%	4,410 $769,000
Q2 2017 Aug 10, 2017	BUY	N/A	4,440	4,440 $627,000

Others Institutions Holding TMO

# of Institutions

2,835

Shares Held

333M

Call Options Held

2.37M

Put Options Held

2.75M

View Full List

About THERMO FISHER SCIENTIFIC INC.

Ticker TMO
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 391,788,992
Market Cap $205B
Description
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...

More about TMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bahl & Gaynor Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bahl & Gaynor Inc with notifications on news.

Account